Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

JETBLUE AIRWAYS CORP (JBLU)

  • SEC News
  • April 28, 2026, 11:02 UTC
  • 0
  • 1 comments

(30% Negative) JETBLUE AIRWAYS CORP (JBLU) Reports Q2 2026 Financial Results

Comment Full text

UBS AG (LONDON BRANCH) (AMUB)

  • SEC News
  • April 28, 2026, 11:02 UTC
  • 0
  • 0 comments

New Form 424B2 - UBS AG <b>Filed:</b> 2026-04-28 <b>AccNo:</b> 0001839882-26-021394 <b>Size:</b> 634 KB

Comment Full text

YANGZIJIANG SHIPBUILDING (HOLDINGS) LTD. (SO7)

  • SEC News
  • April 28, 2026, 11:02 UTC
  • 0
  • 0 comments

Change - Announcement of Cessation: Resignation of Mr Poh Boon Hu Raymond as Independent Non-Executive Director

Comment Full text

CANADIAN IMPERIAL BANK OF COMMERCE /CAN/ (CM)

  • SEC News
  • April 28, 2026, 11:01 UTC
  • 0
  • 0 comments

New Form 424B2 - CANADIAN IMPERIAL BANK OF COMMERCE /CAN/ <b>Filed:</b> 2026-04-28 <b>AccNo:</b> 0001918704-26-010904 <b>Size:</b> 729 KB

Comment Full text

UBS AG (LONDON BRANCH) (AMUB)

  • SEC News
  • April 28, 2026, 11:01 UTC
  • 0
  • 0 comments

New Form 424B2 - UBS AG <b>Filed:</b> 2026-04-28 <b>AccNo:</b> 0001839882-26-021393 <b>Size:</b> 642 KB

Comment Full text

CECO ENVIRONMENTAL CORP (CECO)

  • SEC News
  • April 28, 2026, 11:01 UTC
  • 0
  • 1 comments

(10% Negative) CECO ENVIRONMENTAL CORP (CECO) Reports Q2 2026 Financial Results

Comment Full text

AVALO THERAPEUTICS, INC. (AVTX)

  • SEC News
  • April 28, 2026, 11:01 UTC
  • 0
  • 1 comments

(99% Neutral) AVALO THERAPEUTICS, INC. (AVTX) Announces Enrollment Update for treatments Due to Patient Enrollment Issues, Regulatory Process

Comment Full text

SAGIMET BIOSCIENCES INC. (SGMT)

  • SEC News
  • April 28, 2026, 11:01 UTC
  • 0
  • 1 comments

(99% Neutral) SAGIMET BIOSCIENCES INC. (SGMT) Announces Clinical Development Update

Comment Full text

COCA COLA CO (KO)

  • SEC News
  • April 28, 2026, 11:00 UTC
  • 0
  • 1 comments

(30% Negative) COCA COLA CO (KO) Reports Q2 2026 Financial Results

Comment Full text

PASSAGE BIO, INC. (PASG)

  • SEC News
  • April 28, 2026, 11:00 UTC
  • 0
  • 1 comments

(99% Neutral) PASSAGE BIO, INC. (PASG) Announces Business Combination

Comment Full text
  • Previous
  • 1000
  • 1001
  • 1002
  • 1003
  • 1004
  • Next

Search

News categories

  • Technical Exchange News(12220)
  • Event(6113)
  • SEC News(262591)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(153957)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin